Emergent BioSolutions | Azione





Azione Cambiamento Data
Acadia Pharmaceuticals USD 29.1M 2.97M 2025-09
Akebia Therapeutics USD 18.64M 1.93M 2025-09
ALKERMES USD 191M 927K 2025-09
Alnylam Pharmaceuticals USD 82.72M 7.34M 2025-12
Amarin USD 184.7M 13.46M 2025-09
ANI Pharmaceuticals USD 146.48M 8.16M 2025-09
BioMarin Pharmaceutical USD 1.38B 42M 2025-09
Coherus Biosciences USD 2.05M 2.46M 2025-09
Emergent BioSolutions USD 328.9M 25.2M 2023-12
Exact Sciences USD 166.2M 1.42M 2025-12
Exelixis USD 27.4M 3.92M 2025-09
Glaxosmithkline GBP 6.12B 46M 2025-09
Heron Therapeutics USD 54.57M 2.33M 2022-12
Ionis Pharmaceuticals USD 10.47M 1.99M 2025-09
Lexicon Pharmaceuticals USD 168K 33K 2025-06
Lonza CHF 1.68B 163M 2025-12
Merck USD 6.44B 157M 2025-09
Moderna USD 332M 92M 2025-09
Myriad Genetics USD 31.6M 2.9M 2025-09
Nektar Therapeutics USD 14.46M 1.78M 2024-06
Neurocrine Biosciences USD 69M 300K 2025-12
Pacira USD 157.68M 9.52M 2025-09
Pfizer USD 11.47B 201M 2025-09
PTC Therapeutics USD 52.69M 18.63M 2025-09
Sanofi EUR 22.69B 1.81B 2025-12
Sarepta Therapeutics USD 1.08B 83.13M 2025-09
United Therapeutics USD 176.5M 7.3M 2025-09
Vanda Pharmaceuticals USD 1.85M 190K 2025-12


Emergent BioSolutions Azione - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.